Skip to main content
. 2021 Mar 23;10(6):1320. doi: 10.3390/jcm10061320

Table 1.

Participants ‘demographic and clinical characteristics (n = 57).

Mean ± Sd, Median [IQR] or n (%)
Age (years) 58.2 ± 11.1
Sex, males, n (%) 37 (64.9)
Weight (kg) 80.5 ± 14.5
Height (m) 1.7 ± 0.1
Body Mass Index (kg/m2) 28.6 ± 4.6
Stroke type Ischemic 35 (61.4)
Hemorrhagic 22 (38.6)
Time since stroke onset (months) 64.0 [38.5; 105.5]
Paretic side Right 23 (40.4)
Left 33 (57.9)
Both 1 (1.8)
Living arrangement Alone 6 (10.5)
Accompanied 51 (89.5)
Charlson Comorbidity Index (score) 0.0 [0.0; 1.0]
MoCA, score (0–30) 23.0 [20.0; 25.5]
mRS No disability or slight (%) 36 (63.2)
Moderate or severe disability (%) 21 (36.8)
PHQ9, score (0–27) 5.0 [2.0; 8.0]
SIS-16, score (0–100) 85.9 [73.4; 92.2]
Walking speed (m/s) 0.8 ± 0.4

Sd: Standard deviation, IQR: Interquartile range (25th–75th percentiles), MoCA: Montreal Cognitive Assessment, mRS: Modified Rankin Scale, PHQ-9: The Patient Health Questionnaire-9 and SIS-16: The Stroke Impact Scale-16.